Currently, the decision in most primary care practices to refer men who are asymptomatic is based on binary PSA thresholds, although this can lead to too many false-negative and false-positive results.17 Furthermore, a binary threshold does not give any indication for the patient as to their absolute risk of developing prostate cancer and/or clinically significant disease requiring immediate intervention. The gene discussed is KLK3; the disease is prostate carcinoma.